Editor’s Picks: Notable Gray Sheet Stories From 2013

2013 was a challenging year on some fronts for industry, and the impasses in Congress did not help. But there were some positive policy signals from FDA. There were also some very significant rules finalized – for the unique device identification and the Physician Payment Sunshine Act programs – that signal the need for important implementation efforts in 2014. Here are some of last year’s most important stories from “The Gray Sheet,” based on web hits and editor prerogative.